Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/38683
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSimpson-Yap, Steve-
dc.contributor.authorPIRMANI, Ashkan-
dc.contributor.authorDE BROUWER, Edward-
dc.contributor.authorPEETERS, Liesbet-
dc.contributor.authorGEYS, Lotte-
dc.contributor.authorPARCIAK, Tina-
dc.contributor.authorHelme, Anne-
dc.contributor.authorHillert, Jan-
dc.contributor.authorMoreau, Yves-
dc.contributor.authorEdan, Gilles-
dc.contributor.authorSpelman, Tim-
dc.contributor.authorSharmin , Sifat-
dc.contributor.authorMcBurney, Robert-
dc.contributor.authorSchmidt, Hollie-
dc.contributor.authorBergmann, Arnfin-
dc.contributor.authorBraune, Stefan-
dc.contributor.authorStahmann, Alexander-
dc.contributor.authorMiddleton, Rodden-
dc.contributor.authorSalter, Amber-
dc.contributor.authorBebo, Bruce-
dc.contributor.authorvan der Walt, Anneke-
dc.contributor.authorButzkueven, Helmut-
dc.contributor.authorOzakbas, Serkan-
dc.contributor.authorKarabudak, Rana-
dc.contributor.authorBoz, Cavit-
dc.contributor.authorAlroughani, Raed-
dc.contributor.authorRojas, Juan, I-
dc.contributor.authorvan der Mei, Ingrid-
dc.contributor.authordo Olival, Guilherme Sciascia-
dc.contributor.authorMagyari, Melinda-
dc.contributor.authorAlonso, Ricardo-
dc.contributor.authorNicholas, Richard-
dc.contributor.authorChertcoff, Anibal-
dc.contributor.authorZabalza, Ana-
dc.contributor.authorArrambide, Georgina-
dc.contributor.authorNag, Nupur-
dc.contributor.authorDescamps, Annabel-
dc.contributor.authorCosters, Lars-
dc.contributor.authorDobson, Ruth-
dc.contributor.authorMiller, Aleisha-
dc.contributor.authorRodrigues, Paulo-
dc.contributor.authorPrckovska, Vesna-
dc.contributor.authorComi, Giancarlo-
dc.contributor.authorKalincik, Tomas-
dc.date.accessioned2022-10-03T08:31:52Z-
dc.date.available2022-10-03T08:31:52Z-
dc.date.issued2022-
dc.date.submitted2022-09-28T09:40:28Z-
dc.identifier.citationMultiple sclerosis and related disorders (Print), 66 (Art N° 104072)-
dc.identifier.urihttp://hdl.handle.net/1942/38683-
dc.description.abstractBackground: Interferon-beta, a disease-modifying therapy (DMT) for MS, may be associated with less severe COVID-19 in people with MS. Results: Among 5,568 patients (83.4% confirmed COVID-19), interferon-treated patients had lower risk of severe COVID-19 compared to untreated, but not to glatiramer-acetate, dimethyl-fumarate, or pooled other DMTs. Conclusions: In comparison to other DMTs, we did not find evidence of protective effects of interferon-beta on the severity of COVID-19, though compared to the untreated, the course of COVID-19 was milder among those on interferon-beta. This study does not support the use of interferon-beta as a treatment to reduce COVID-19 severity in MS.-
dc.language.isoen-
dc.publisherELSEVIER SCI LTD-
dc.rights2022 Elsevier B.V. All rights reserved.-
dc.titleSeverity of COVID19 infection among patients with multiple sclerosis treated with interferon-beta-
dc.typeJournal Contribution-
dc.identifier.volume66-
local.bibliographicCitation.jcatA1-
dc.description.notesSimpson-Yap, S (corresponding author), Univ Melbourne, Dept Med, CORe, Melbourne, Vic, Australia.; Simpson-Yap, S (corresponding author), Univ Melbourne, Melbourne Sch Populat & Global Hlth, Neuroepidemiol Unit, Melbourne, Vic, Australia.; Simpson-Yap, S (corresponding author), Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia.-
dc.description.notessteve.simpsonyap@unimelb.edu.au-
local.publisher.placeTHE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND-
local.type.refereedRefereed-
local.type.specifiedLetter-
local.bibliographicCitation.artnr104072-
dc.identifier.doi10.1016/j.msard.2022.104072-
dc.identifier.pmid35917745-
dc.identifier.isi000850461000003-
dc.contributor.orcidZabalza, Ana/0000-0003-3860-5251; Pirmani, Ashkan/0000-0003-4549-1002;-
dc.contributor.orcidSimpson, Jr., Steve/0000-0001-6521-3056-
local.provider.typewosris-
local.description.affiliation[Simpson-Yap, Steve; Sharmin, Sifat; Kalincik, Tomas] Univ Melbourne, Dept Med, CORe, Melbourne, Vic, Australia.-
local.description.affiliation[Simpson-Yap, Steve; Nag, Nupur] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Neuroepidemiol Unit, Melbourne, Vic, Australia.-
local.description.affiliation[Simpson-Yap, Steve] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia.-
local.description.affiliation[Pirmani, Ashkan; Peeters, Liesbet M.; Parciak, Tina] Univ MS Ctr, UMSC Hasselt Pelt, Hasselt, Belgium.-
local.description.affiliation[Pirmani, Ashkan; Peeters, Liesbet M.; Parciak, Tina] Hasselt Univ, Biomed Res Inst, Data Sci Inst, Hasselt, Belgium.-
local.description.affiliation[Pirmani, Ashkan; Peeters, Liesbet M.; Geys, Lotte; Parciak, Tina] Hasselt Univ, Biomed Res Inst BIOMED, Agoralaan Bldg C, B-3590 Diepenbeek, Belgium.-
local.description.affiliation[Pirmani, Ashkan; Peeters, Liesbet M.; Geys, Lotte; Parciak, Tina] Hasselt Univ, Data Sci Inst DSI, Agoralaan Bldg, B-3590 Diepenbeek, Belgium.-
local.description.affiliation[Pirmani, Ashkan; De Brouwer, Edward; Moreau, Yves] Katholieke Univ Leuven, ESAT STADIUS, Leuven, Belgium.-
local.description.affiliation[Helme, Anne] MS Int Federat, London, England.-
local.description.affiliation[Hillert, Jan; Spelman, Tim] Swedish MS Registry, Dept Clin Neurosci, Stockholm, Sweden.-
local.description.affiliation[Hillert, Jan; Spelman, Tim] Karolinska Inst, Stockholm, Sweden.-
local.description.affiliation[Edan, Gilles] CHU Pontchaillou, Dept Neurol, Rennes, France.-
local.description.affiliation[McBurney, Robert; Schmidt, Hollie] Accelerated Cure Project MS, iConquerMS People Powered Res Network, Waltham, MA USA.-
local.description.affiliation[Bergmann, Arnfin; Braune, Stefan] NeuroTransData, NeuroTransData Study Grp, Neuburg, Germany.-
local.description.affiliation[Stahmann, Alexander] MS Forschungs & ProjektentwicklungsgGmbH, German MSRegister Natl MS Soc, Hannover, Germany.-
local.description.affiliation[Middleton, Rodden; Nicholas, Richard] Swansea Univ, UK MS Register, Swansea, W Glam, Wales.-
local.description.affiliation[Salter, Amber; Bebo, Bruce] COViMS, New York, NY USA.-
local.description.affiliation[Salter, Amber] Washington Univ, Div Biostat, St Louis, MO USA.-
local.description.affiliation[van der Walt, Anneke; Butzkueven, Helmut] Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic, Australia.-
local.description.affiliation[Ozakbas, Serkan] Amiri Hosp, Kuwait, Kuwait.-
local.description.affiliation[Karabudak, Rana] Hacettepe Univ, Dept Neurol, Ankara, Turkey.-
local.description.affiliation[Boz, Cavit] Karadeniz Tech Univ, Dept Neurol, Trabzon, Turkey.-
local.description.affiliation[Alroughani, Raed] Dokuz Eylul Univ, Izmir, Turkey.-
local.description.affiliation[Rojas, Juan, I] Hosp Univ CEMIC, Neurol Dept, Pilar, Argentina.-
local.description.affiliation[Rojas, Juan, I; Alonso, Ricardo] RELACOEM, Buenos Aires, DF, Argentina.-
local.description.affiliation[van der Mei, Ingrid] Univ Tasmania, Menzies Inst Med Res, Australian MS Longitudinal Study, Hobart, Tas, Australia.-
local.description.affiliation[do Olival, Guilherme Sciascia] ABEM Brazilian MS Patients Assoc, Sao Paulo, Brazil.-
local.description.affiliation[Magyari, Melinda] Rigshosp, Dept Neurol, Danish Multiple Sclerosis Registry, Univ Hosp, Copenhagen, Denmark.-
local.description.affiliation[Alonso, Ricardo] Multiple Sclerosis Univ Ctr, Ramos Mejia Hosp EMA, Buenos Aires, DF, Argentina.-
local.description.affiliation[Nicholas, Richard; Miller, Aleisha] Imperial Coll London, London, England.-
local.description.affiliation[Chertcoff, Anibal] Hosp Britan Buenos Aires, EMA, MS & Demyelinating Dis, Buenos Aires, DF, Argentina.-
local.description.affiliation[Zabalza, Ana; Arrambide, Georgina] Univ Autonoma Barcelona, Vall Hebron Inst Recerca, Ctr Esclerosi Multiple Catalunya Cemcat, Serv Neurol Neuroimmunol,Ctr Esclerosi Multiple C, Barcelona, Spain.-
local.description.affiliation[Descamps, Annabel; Costers, Lars] Icometrix, Leuven, Belgium.-
local.description.affiliation[Dobson, Ruth] Queen Mary Univ London, London, England.-
local.description.affiliation[Rodrigues, Paulo; Prckovska, Vesna] QMENTA Inc, Barcelona, Spain.-
local.description.affiliation[Comi, Giancarlo] Casa Cura Policlin, Milan, Italy.-
local.description.affiliation[Comi, Giancarlo] Univ Vita Salute San Raffaele, Milan, Italy.-
local.description.affiliation[Kalincik, Tomas] Royal Melbourne Hosp, MS Ctr, Dept Neurol, Melbourne, Vic, Australia.-
local.uhasselt.internationalyes-
item.fullcitationSimpson-Yap, Steve; PIRMANI, Ashkan; DE BROUWER, Edward; PEETERS, Liesbet; GEYS, Lotte; PARCIAK, Tina; Helme, Anne; Hillert, Jan; Moreau, Yves; Edan, Gilles; Spelman, Tim; Sharmin , Sifat; McBurney, Robert; Schmidt, Hollie; Bergmann, Arnfin; Braune, Stefan; Stahmann, Alexander; Middleton, Rodden; Salter, Amber; Bebo, Bruce; van der Walt, Anneke; Butzkueven, Helmut; Ozakbas, Serkan; Karabudak, Rana; Boz, Cavit; Alroughani, Raed; Rojas, Juan, I; van der Mei, Ingrid; do Olival, Guilherme Sciascia; Magyari, Melinda; Alonso, Ricardo; Nicholas, Richard; Chertcoff, Anibal; Zabalza, Ana; Arrambide, Georgina; Nag, Nupur; Descamps, Annabel; Costers, Lars; Dobson, Ruth; Miller, Aleisha; Rodrigues, Paulo; Prckovska, Vesna; Comi, Giancarlo & Kalincik, Tomas (2022) Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-beta. In: Multiple sclerosis and related disorders (Print), 66 (Art N° 104072).-
item.validationecoom 2023-
item.contributorSimpson-Yap, Steve-
item.contributorPIRMANI, Ashkan-
item.contributorDE BROUWER, Edward-
item.contributorPEETERS, Liesbet-
item.contributorGEYS, Lotte-
item.contributorPARCIAK, Tina-
item.contributorHelme, Anne-
item.contributorHillert, Jan-
item.contributorMoreau, Yves-
item.contributorEdan, Gilles-
item.contributorSpelman, Tim-
item.contributorSharmin , Sifat-
item.contributorMcBurney, Robert-
item.contributorSchmidt, Hollie-
item.contributorBergmann, Arnfin-
item.contributorBraune, Stefan-
item.contributorStahmann, Alexander-
item.contributorMiddleton, Rodden-
item.contributorSalter, Amber-
item.contributorBebo, Bruce-
item.contributorvan der Walt, Anneke-
item.contributorButzkueven, Helmut-
item.contributorOzakbas, Serkan-
item.contributorKarabudak, Rana-
item.contributorBoz, Cavit-
item.contributorAlroughani, Raed-
item.contributorRojas, Juan, I-
item.contributorvan der Mei, Ingrid-
item.contributordo Olival, Guilherme Sciascia-
item.contributorMagyari, Melinda-
item.contributorAlonso, Ricardo-
item.contributorNicholas, Richard-
item.contributorChertcoff, Anibal-
item.contributorZabalza, Ana-
item.contributorArrambide, Georgina-
item.contributorNag, Nupur-
item.contributorDescamps, Annabel-
item.contributorCosters, Lars-
item.contributorDobson, Ruth-
item.contributorMiller, Aleisha-
item.contributorRodrigues, Paulo-
item.contributorPrckovska, Vesna-
item.contributorComi, Giancarlo-
item.contributorKalincik, Tomas-
item.fulltextWith Fulltext-
item.accessRightsOpen Access-
crisitem.journal.issn2211-0348-
crisitem.journal.eissn2211-0356-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-β.pdf
  Restricted Access		Published version405.02 kBAdobe PDFView/Open    Request a copy
Auteursversie.pdfPeer-reviewed author version321.3 kBAdobe PDFView/Open
Show simple item record

WEB OF SCIENCETM
Citations

5
checked on May 8, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.